Splicing factor mutations and cancer

Yoshida, Kenichi, Ogawa, Seishi·2014·WIREs RNA
DOI 10.1002/wrna.1222

Cited by (155)

Items 101–155 of 155

  1. Chemical Modulation of Alternative Splicing for Molecular-Target Identification by Potential Genetic Control in Agrochemical Research
    Mo‐Xian Chen, Boyagane D. I. K. Wijethunge, Shao-Ming Zhou, Jing-Fang Yang, Lei Dai, Shanshan Wang, Chen Chen, Li-Jun Fu, Jianhua Zhang, Ge‐Fei Hao et al. · 2019 · Journal of Agricultural and Food Chemistry
  2. The role of splicing factor PRPF8 in breast cancer
    Difei Cao, Jiaying Xue, Guoqing Huang, Jing An, Weiwei An · 2022 · Technology and Health Care
  3. A common structural mechanism for RNA recognition by the SF3B complex in mRNA splicing and export
    Yuzhu Zhang, Changping Yin, Yimin Wang, Kunming Yan, Bo Zhao, Xin Hu, Youzhong Wan, Hong Cheng, Jing Huang · 2025 · Nucleic Acids Research
  4. U2AF65-Dependent SF3B1 Function in SMN Alternative Splicing
    Namjeong Choi, Yongchao Liu, Jagyeong Oh, Jiyeon Ha, Xuexiu Zheng, Haihong Shen · 2020 · Cells
  5. RNA splicing as a therapeutic target in myelodysplastic syndromes
    Chun-Chih Tseng, Esther A. Obeng · 2024 · Seminars in Hematology
  6. Cdc48 regulates intranuclear quality control sequestration of the Hsh155 splicing factor in budding yeast
    Veena Mathew, Arun Kumar, Yangyang Kate Jiang, Kyra West, Annie Tam, Peter C. Stirling · 2020 · Journal of Cell Science
  7. DNMT3B splicing dysregulation mediated by SMCHD1 loss contributes to DUX4 overexpression and FSHD pathogenesis
    Eden Engal, Aveksha Sharma, Uria Aviel, Nadeen Taqatqa, Sarah Juster, Shiri Jaffe‐Herman, Mercedes Bentata, Ophir Geminder, Adi Gershon, Reyut Lewis et al. · 2024 · Science Advances
  8. Studying the connection between SF3B1 and four types of cancer by analyzing networks constructed based on published research
    Asmaa Samy, Mehmet Kemal Özdemir, Reda Alhajj · 2023 · Scientific Reports
  9. Systemic characterization of alternative splicing related to prognosis and immune infiltration in malignant mesothelioma
    Jinzhi Lai, Hainan Yang, Tianwen Xu · 2021 · BMC Cancer
  10. Two oppositely-charged sf3b1 mutations cause defective development, impaired immune response, and aberrant selection of intronic branch sites in Drosophila
    Bei Zhang, Zhan Ding, Liang Li, Ling-Kun Xie, Yujie Fan, Yong‐Zhen Xu · 2021 · PLoS Genetics
  11. Bone marrow niches in myeloid neoplasms
    Masanobu Kitagawa, Morito Kurata, Iichiroh Onishi, Kouhei Yamamoto · 2019 · Pathology International
  12. Comprehensive Genomic Characterization in Ovarian Low-Grade and Chemosensitive and Chemoresistant High-Grade Serous Carcinomas
    Carolina O. Jaliffa, Uwe Rogel, Indrani Sen, Gad Singer · 2024 · Oncology
  13. A glimpse on Staphylococcus aureus translation machinery and its control
    Iskander Sh. Khusainov, Alessandra Marenna, Marie Cerciat, Pierre Fechter, Yaser Hashem, Stefano Marzi, Pascale Romby, Gulnara Zh. Yusupova, Marat Yusupov · 2016 · Molecular Biology
  14. Distinct Minor Splicing Patterns across Cancers
    Lauren A. Levesque, Nicole Salazar, Scott William Roy · 2022 · Genes
  15. Rewards of divergence in sequences, 3-D structures and dynamics of yeast and human spliceosome SF3b complexes
    Arangasamy Yazhini, Sankaran Sandhya, Narayanaswamy Srinivasan · 2021 · Current Research in Structural Biology
  16. Comprehensive splicing analysis of the alternatively spliced CHEK2 exons 8 and 10 reveals three enhancer/silencer‐rich regions and 38 spliceogenic variants
    Lara Sanoguera‐Miralles, Inés Llinares‐Burguet, Elena Bueno‐Martínez, Lobna Ramadane‐Morchadi, Cristiana Stuani, Alberto Valenzuela‐Palomo, Alicia García‐Álvarez, Pedro Pérez‐Segura, Emanuele Buratti, Miguel de la Hoya et al. · 2024 · The Journal of Pathology
  17. Exon-centric regulation of ATM expression is population-dependent and amenable to antisense modification by pseudoexon targeting
    Jana Královičová, Marcin Knut, Nicholas C.P. Cross, Igor Vořechovský · 2016 · Scientific Reports
  18. Alternative Splicing and CaV ‐Associated Channelopathies
    Willy Munyao, Md. Mostafizur Rahman, Samuel Sabzanov, Elizabeth H. Chu, Ruizhi Wang, Zhifei Wang, Yong Yu, Matteo Ruggiu · 2025 · Wiley Interdisciplinary Reviews - RNA
  19. Prognostic Value and Potential Regulatory Mechanism of Alternative Splicing in Geriatric Breast Cancer
    Xin Li, Yaxuan Wang, Bingjie Li, Wang Ma · 2020 · Genes
  20. Genetic variants in splicing factor genes and susceptibility to bladder cancer
    Xi Wang, Zheng Guo, Huanhuan Zhu, Junyi Xin, Lin Yuan, Chao Qin, Meilin Wang, Zhengdong Zhang, Yunyan Wang, Haiyan Chu · 2021 · Gene
  21. SF3B1 modulators affect key genes in metastasis and drug influx: a new approach to fight pancreatic cancer chemoresistance
    Ornella Randazzo, Stella Cascioferro, Camilla Pecoraro, Widad Ait Iddouch, Amir Avan, Barbara Parrino, Daniela Carbone, Ugo Perricone, Godefridus J. Peters, Patrizia Diana et al. · 2021 · Cancer Drug Resistance
  22. Development of a High-Resolution Melting Curve Analysis Screening Test for SRSF2 Splicing Factor Gene Mutations in Myelodysplastic Syndromes
    Eduardo Garza, Emiliano Fabiani, Nélida I. Noguera, Paola Panetta, Maria Liliana Piredda, Loredana Borgia, Luca Maurillo, Gianfranco Catalano, Maria Teresa Voso, Francesco Lo‐Coco · 2014 · Journal of Molecular Diagnostics
  23. KSHV reprograms host RNA splicing via FAM50A to activate STAT3 and drive oncogenic cellular transformation
    Shenyu Sun, Karla Paniagua, Ling Ding, Xian Wang, Yufei Huang, Mario A. Flores, Shou‐Jiang Gao · 2025 · mBio
  24. Evolutionary trajectories of myelodysplastic syndromes/neoplasms
    Maria Creignou, Martina Sarchi, Elsa Bernard, Luca Malcovati · 2026 · Seminars in Cancer Biology
  25. Emerging roles of alternative RNA splicing in oral squamous cell carcinoma
    Miaomiao Liu, Jihua Guo, Rong Jia · 2022 · Frontiers in Oncology
  26. Nested small open reading frames are translated from alternative transcripts
    Haomiao Su, Samuel G. Katz, Sarah A. Slavoff · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  27. Functional screens identify coordinators of RNA molecule birth, life, and death as targetable cancer vulnerabilities
    Christian Joerg Braun, Michael T. Hemann · 2019 · Current Opinion in Genetics & Development
  28. Alternative splicing in neuroblastoma generates RNA-fusion transcripts and is associated with vulnerability to spliceosome inhibitors
    Yao Shi, Vilma Rraklli, Eva Maxymovitz, Shuijie Li, Isabelle Westerlund, Oscar C. Bedoya-Reina, Juan Yuan, Petra Bullova, C. Christofer Juhlin, Adam Stenman et al. · 2019 · bioRxiv (Cold Spring Harbor Laboratory)
  29. Transcripts of splicing factors with time-varying associations with survival outcomes in colorectal cancer
    Yajun Yu · 2025 · American Journal of Cancer Research
  30. BAY61-3606 Alters snRNP Composition and Enhances Usage of Suboptimal Splice Acceptor Site
    Kenji Tomita, Shinichi Nakagawa, Hiroyoshi Ariga, Hiroshi Maita · 2023 · Biological and Pharmaceutical Bulletin
  31. Impaired dNKAP function drives genome instability and tumorigenic growth in Drosophila epithelia
    Ting Guo, Chen Miao, Zhonghua Liu, Jingwei Duan, Yanbin Ma, Xiao Zhang, Weiwei Yang, Maoguang Xue, Qiannan Deng, Pengfei Guo et al. · 2023 · Journal of Molecular Cell Biology
  32. Assessing the Impact of Novel BRCA1 Exon 11 Variants on Pre-mRNA Splicing
    Halla Elshwekh, Inas M. Alhudiri, Adam I. Elzagheid, Nabil Sabri Enattah, Yasmine Abbassi, Lubna Abou Assali, Ilenia Marino, Cristiana Stuani, Emanuele Buratti, Maurizio Romano · 2024 · Cells
  33. The Role of the Exonic lncRNA PRKDC-210 in Transcription Regulation
    Junling Mo, Guangyao Fan, Toshifumi Tsukahara, Matomo Sakari · 2022 · International Journal of Molecular Sciences
  34. SF3B1-dependent alternative splicing is critical for maintaining endometrial homeostasis and the establishment of pregnancy
    Pooja Popli, Sangappa Basanna Chadchan, Michelle Dias, Xinchao Deng, Stephanie Gunderson, Patricia T. Jimenez, Hari Krishna Yalamanchili, Ramakrishna Kommagani · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  35. Decoding RAP1 ’s Role in Yeast mRNA Splicing
    Siddhant Kalra, Joseph D. Coolon · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  36. Alternative Splicing in Breast Cancer
    Yesim Gökmen‐Polar · 2016 · Springer eBooks
  37. Developmental Variation in the Nuclear Genome Primary Sequence
    Xiu‐Qing Li · 2017
  38. Investigation of the effects of the splicing inhibitor Pladienolide B and cancer-related mutations in the SF3b1 protein on pre-mRNA splicing in vitro
    Ludwig, Sebastian · 2020
  39. SEC23A Regulated by Splicing Factor EIF3A may be Involved in the Development of Cervical Squamous Cell Cancer via Adherens Junction Pathway
    Chen Li, Fang Yan, Ting Wan, Haifeng Gu, Gang Chen, Qiang Li, Hua Xian, Jingdun Xie · 2020
  40. Λειτουργική ανάλυση του γονιδίου FRA10AC1 του ανθρώπου στο πλαίσιο του δικτύου πρωτεϊνικών αλληλεπιδράσεων του σωματίου συναρμογής
    Ελένη Γαλλιοπούλου · 2018
  41. Comprehensive analysis of alternative splicing and transcriptome related to the prognosis of cervical squamous cell cancer
    Chen Li, Fang Yan, Gang Chen, Qiang Li, Hua Xian, Jingdun Xie · 2020
  42. Data from Nonsense-Mediated RNA Decay Is a Unique Vulnerability of Cancer Cells Harboring SF3B1 or U2AF1 Mutations
    Abigael Cheruiyot, Shan Li, Sridhar Nonavinkere Srivatsan, Tanzir Ahmed, Yuhao Chen, Delphine Sangotokun Lemacon, Ying Li, Zheng Yang, Brian A. Wadugu, Wayne A. Warner et al. · 2023
  43. Data from Nonsense-Mediated RNA Decay Is a Unique Vulnerability of Cancer Cells Harboring SF3B1 or U2AF1 Mutations
    Abigael Cheruiyot, Shan Li, Sridhar Nonavinkere Srivatsan, Tanzir Ahmed, Yuhao Chen, Delphine Sangotokun Lemacon, Ying Li, Zheng Yang, Brian A. Wadugu, Wayne A. Warner et al. · 2023
  44. Alternative Splicing and Cancer
    Arpankumar Choksi, Richa Pant, Kiran Kumar Nakka, Meghna Singh, Akshita Upreti, Samit Chattopadhyay · 2023 · Springer eBooks
  45. DNMT3B splicing dysregulation mediated by SMCHD1 loss contributes to DUX4 overexpression and FSHD pathogenesis
    Maayan Salton, Eden Engal, Aveksha Sharma, Nadeen Taqatqa, Mercedes Bentata, Shiri Jaffe‐Herman, Ophir Geminder, Reyut Lewis, Marc Gotkine, Rachel Eiges et al. · 2023 · Research Square
  46. Identification of BAY61 ‐3606 Derivatives With Improved Activity in Splicing Modulation That Induces Inclusion of Cassette Exons Similar to the Splicing Factor 3B Subunit 1 Mutation
    Takanori Matsumaru, Toshiki Iwamatsu, Kana Ishigami, Makoto Inai, Wataru Kanto, Ayumi Ishigaki, Atsushi Toyoda, Satoshi Shuto, Katsumi Maenaka, Shinichi Nakagawa et al. · 2024 · Chemical Biology & Drug Design
  47. Assessment of SF3B1 Expression as a Prognostic Marker for Neoadjuvant Chemotherapy Response in Stage III Triple-Negative Breast Cancer
    Desak Made Wihandani, Putu Anda Tusta Adiputra, Gede Wikania Wira Wiguna Wiguna, Putu Gede Septiawan Saputra, Made Violin Weda Yani, Ida Ayu Widya Anjani, Wayan Ardyan Sudartha Putra, Gede Putu Supadmanaba · 2025 · Reports of Biochemistry and Molecular Biology
  48. SF3B1 phosphorylation is an evolutionarily conserved step in spliceosome activation carried out by the divergent, OTS964-insensitive kinase CRK9 in trypanosomes
    Kazuya Machida, Priyanka Rattan, Sofia Cassidento, Nuala Peterman, Bing Hao, Arthur Günzl · 2026 · Nucleic Acids Research
  49. Genome-wide modulation of alternative splicing by a predicted alpha helix in U2AF2
    Dingwu Xue, Liqiang Ai, Xiaoqin Wang, Yuxin Liu, Yuxuan Zhao, Jun Ma, Ranhui Duan, Long Ma · 2025 · Nucleic Acids Research
  50. Additional file 1 of Systemic characterization of alternative splicing related to prognosis and immune infiltration in malignant mesothelioma
    Lai, Jinzhi, Hainan Yang, Xu, Tianwen · 2021 · Figshare
  51. Étude de l’épissage alternatif des transcrits induits par Aire dans le thymus
    Francine Padonou · 2020 · theses.fr (ABES)
  52. Approche à large échelle visant à détecter de nouveaux régulateurs de l'épissage alternatif au cours de la transition épithélio-mésenchymateuse.
    Jean-Philippe Villemin · 2020
  53. Nouvelle stratégie d'annotation des génomes par l'utilisation d'algorithmes d'intelligence artificielle
    Nicolas Scalzitti · 2021 · theses.fr (ABES)
  54. Rôle des Hématopoïèses clonales de potentiel indéterminé (CHIP) dans la physiopathologie des maladies cardiovasculaires
    Mélody Dufossée · 2024
  55. From bone marrow failure to myeloid malignancies: Multi-dimensional mechanistic insights and therapeutic perspectives
    Jicheng Ding, Yimeng Jiang, Zhengrong Xu, Ying Zheng, Lili Pan · 2026 · Cell investigation.